南非约翰内斯堡HIV血清阳性女性宫颈异型增生治疗中冷冻疗法与环形电切术的随机临床试验比较
该随机临床试验纳入166例HIV血清阳性、组织学证实宫颈上皮内瘤变≥2级的18-65岁女性,1:1随机接受冷冻疗法或环形电切术。6个月时冷冻疗法组宫颈上皮内瘤变≥2级累积发生率高于环形电切术组(24.3% vs 10.8%,P=.02),但12个月时差异无统计学意义(27.2% vs 18.5%,P=.21)。两种治疗在12个月时均使宫颈上皮内瘤变≥2级降低>70%,但复发率仍较高,作者认为应考虑不同治疗方案。
要点
- 6个月时冷冻疗法组宫颈上皮内瘤变≥2级累积发生率24.3%,高于环形电切术组10.8%(P=.02)。
- 12个月时两组宫颈上皮内瘤变≥2级累积发生率差异无统计学意义(27.2% vs 18.5%,P=.21)。
- 两种治疗在12个月时均使宫颈上皮内瘤变≥2级降低>70%,但复发率仍较高。
核心结论
- 6个月时环形电切术组宫颈上皮内瘤变≥2级累积发生率低于冷冻疗法组,但12个月时两种方法差异无统计学意义。
- 两种治疗在12个月时均使宫颈上皮内瘤变≥2级降低>70%,但両组均观察到较高的宫颈上皮内瘤变≥2级复发率,提示治疗失败。
- 作者认为应考虑不同的治疗方案以优化HIV血清阳性女性宫颈上皮内瘤变≥2级的治疗。
研究设计与样本
- 随机临床试验,纳入166例HIV血清阳性、年龄18-65岁、组织学证实宫颈上皮内瘤变≥2级的女性,1:1随机接受冷冻疗法或环形电切术。
- 研究在约翰内斯堡一家政府医院进行,注册号ClinicalTrials.gov NCT01723956。
- 主要比较治疗后6个月和12个月宫颈上皮内瘤变≥2级累积发生率,次要终点包括组织学宫颈上皮内瘤变≥3级和≥1级、高危和低危宫颈细胞学。
主要发现
- 6个月时冷冻疗法组宫颈上皮内瘤变≥2级累积发生率为24.3%(95%CI 16.1-35.8),环形电切术组为10.8%(95%CI 5.7-19.8),P=.02。
- 12个月时冷冻疗法组宫颈上皮内瘤变≥2级累积发生率为27.2%(95%CI 18.5-38.9),环形电切术组为18.5%(95%CI 11.6-28.8),P=.21。
- 6个月时冷冻疗法组宫颈上皮内瘤变≥1级累积发生率为89.2%(95%CI 80.9-94.9),环形电切术组为78.3%(95%CI 68.9-86.4),P=.06;12个月时冷冻疗法组为98.5%(95%CI 92.7-99.8),环形电切术组为89.8%(95%CI 82.1-95.2),P=.02。
- 6个月时冷冻疗法组高危细胞学累积发生率为41.9%,环形电切术组为18.1%(P<.01);12个月时分别为44.8% vs 19.4%(P<.001)。
- 6个月时冷冻疗法组低危细胞学或以上累积发生率为90.5%,环形电切术组为80.7%(P=.08);12个月时分别为100% vs 94.8%(P=.03)。
关键数值与推荐
- 6个月时冷冻疗法组宫颈上皮内瘤变≥2级累积发生率为24.3%(95%CI 16.1-35.8),环形电切术组为10.8%(95%CI 5.7-19.8)。
- 12个月时冷冻疗法组宫颈上皮内瘤变≥2级累积发生率为27.2%(95%CI 18.5-38.9),环形电切术组为18.5%(95%CI 11.6-28.8)。
- 12个月时两组宫颈上皮内瘤变≥2级累积发生率差异无统计学意义(P=.21)。
- 两种治疗在12个月时均使宫颈上皮内瘤变≥2级降低>70%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 12个月时两组宫颈上皮内瘤变≥2级累积发生率差异无统计学意义,置信区间较宽。
- 両组均观察到较高的宫颈上皮内瘤变≥2级复发率,提示治疗失败。
- 作者认为应考虑不同的治疗方案以优化HIV血清阳性女性宫颈上皮内瘤变≥2级的治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mortality associated with cervical cancer is a public health concern for women, particularly in HIV-seropositive women in resource-limited countries. HIV-seropositive women are at a higher risk of high-grade cervical precancer, which can eventually progress to invasive carcinoma as compared to HIV-seronegative women. It is imperative to identify effective treatment methods for high-grade cervical precursors among HIV-seropositive women. OBJECTIVE: Randomized controlled trial data are needed comparing cryotherapy vs loop electrosurgical excision procedure treatment efficacy in HIV-seropositive women. Our primary aim was to compare the difference in the efficacy of loop electrosurgical excision procedure vs cryotherapy for the treatment of high-grade cervical intraepithelial neoplasia (grade ≥2) among HIV-seropositive women by conducting a randomized clinical trial. STUDY DESIGN: HIV-seropositive women (n = 166) aged 18-65 years with histology-proven cervical intraepithelial neoplasia grade ≥2 were randomized (1:1) to cryotherapy or loop electrosurgical excision procedure treatment at a government hospital in Johannesburg. Treatment efficacy was compared using 6- and 12-month cumulative incidence posttreatment of: (1) cervical intraepithelial neoplasia grade ≥2; (2) secondary endpoints of histologic cervical intraepithelial neoplasia grade ≥3 and grade ≥1; and (3) high-grade and low-grade cervical cytology. The study was registered (ClinicalTrials.govNCT01723956). RESULTS: From January 2010 through August 2014, 166 participants were randomized (86 loop electrosurgical excision procedure; 80 cryotherapy). Cumulative cervical intraepithelial neoplasia grade ≥2 incidence was higher for cryotherapy (24.3%; 95% confidence interval, 16.1-35.8) than loop electrosurgical excision procedure at 6 months (10.8%; 95% confidence interval, 5.7-19.8) (P = .02), although by 12 months, the difference was not significant (27.2%; 95% confidence interval, 18.5-38.9 vs 18.5%; 95% confidence interval, 11.6-28.8, P = .21). Cumulative cervical intraepithelial neoplasia grade ≥1 incidence for cryotherapy (89.2%; 95% confidence interval, 80.9-94.9) did not differ from loop electrosurgical excision procedure (78.3%; 95% confidence interval, 68.9-86.4) at 6 months (P = .06); cumulative cervical intraepithelial neoplasia grade ≥1 incidence by 12 months was higher for cryotherapy (98.5%; 95% confidence interval, 92.7-99.8) than loop electrosurgical excision procedure (89.8%; 95% confidence interval, 82.1-95.2) (P = .02). Cumulative high-grade cytology incidence was higher for cryotherapy (41.9%) than loop electrosurgical excision procedure at 6 months (18.1%, P < .01) and 12 months (44.8% vs 19.4%, P < .001). Cumulative incidence of low-grade cytology or greater in cryotherapy (90.5%) did not differ from loop electrosurgical excision procedure at 6 months (80.7%, P = .08); by 12 months, cumulative incidence of low-grade cytology or greater was higher in cryotherapy (100%) than loop electrosurgical excision procedure (94.8%, P = .03). No serious adverse effects were recorded. CONCLUSION: Although rates of cumulative cervical intraepithelial neoplasia grade ≥2 were lower after loop electrosurgical excision procedure than cryotherapy treatment at 6 months, both treatments appeared effective in reducing cervical intraepithelial neoplasia grade ≥2 by >70% by 12 months. The difference in cumulative cervical intraepithelial neoplasia grade ≥2 incidence between the 2 treatment methods by 12 months was not statistically significant. Relatively high cervical intraepithelial neoplasia grade ≥2 recurrence rates, indicating treatment failure, were observed in both treatment arms by 12 months. A different treatment protocol should be considered to optimally treat cervical intraepithelial neoplasia grade ≥2 in HIV-seropositive women.
引用
- Smith JS, Sanusi B, Swarts A, et al. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. Am J Obstet Gynecol. 2017. PMID: 28366730. doi:10.1016/j.ajog.2017.03.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。